Teclistamab User Reviews & Ratings
Brand names: Tecvayli
Teclistamab has an average rating of 9.5 out of 10 from a total of 2 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Multiple Myeloma | 2 reviews for Multiple Myeloma | 68 medications | |
| Add your review | |||
- Lowell
- Taken for 1 to 6 months
- June 4, 2024
Tecvayli (teclistamab) for Multiple Myeloma "So far, so good, my numbers are excellent and in remission!"
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about teclistamab
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
For Multiple Myeloma "So far, so good. Experienced swelling and redness at injection site after the first 4-5 treatments, but the swelling and redness went away after 3-4 days. Now having very itchy little bumps all over both arms. Neuropathy has increased severely, with numbness, tingling, and burning in both hands, and aching in all arm and hand joints, including shoulder joints. Numbness in feet."